Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 57.5B | 57.5B | 57.3B | 53.5B |
Cost of revenue | 21.6B | 19.7B | 24.2B | 19.1B |
Gross profit | 35.8B | 37.8B | 33.1B | 34.4B |
Operating expense | ||||
Research & development | — | 2.3B | 3.0B | 2.1B |
Selling general and admin | 30.2B | 14.4B | 14.0B | 14.6B |
Other operating expenses | — | 557.3M | 254.9M | 103.0M |
Operating income | 35.8B | 8.9B | 3.9B | 4.6B |
Non operating interest income | ||||
Income | — | 58.7M | 65.3M | 74.0M |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 5.5B | 7.9B | 3.9B | 5.7B |
Tax provision | 1.3B | 730.5M | 942.8M | 637.1M |
Net income | 4.2B | 7.2B | 3.0B | 5.0B |
Basic EPS | 245.1 | — | 171 | 291 |
Diluted EPS | 245.1 | — | 171 | 291 |
Basic average shares | — | — | 17.3M | 17.3M |
Diluted average shares | — | — | 17.3M | 17.3M |
EBITDA | 35.8B | 12.3B | 6.1B | 6.5B |
Net income from continuing op. | — | 7.2B | 3.0B | 5.0B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |